Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy | Up to 8 years |
| Measure | Description | Time Frame |
|---|---|---|
| LDL-cholesterol levels | Up to 8 years | |
| HDL-cholesterol levels | Up to 8 years | |
| Proportion of patients having raised levels of serum CK or ALT |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Patients from primary care and specialist clinics
Not provided
| Name | Affiliation | Role |
|---|---|---|
| DR ARTHUR TAN, MBBS | ARTHUR TAN HEART CLINIC, GLENEAGLES MEDICAL CENTRE | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Singapore | Singapore |
Not provided
| ID | Term |
|---|---|
| D006937 | Hypercholesterolemia |
| ID | Term |
|---|---|
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Up to 8 years |
| D009750 |
| Nutritional and Metabolic Diseases |